Affimed Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Shawn Leland
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 7.3yrs |
Board average tenure | 9.5yrs |
Recent management updates
Recent updates
Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts
Sep 04Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better
Jun 11The Affimed N.V. (NASDAQ:AFMD) Analysts Have Been Trimming Their Sales Forecasts
Aug 15Affimed downgraded to hold at Stifel as pipeline lacks development clarity
Oct 10Health Check: How Prudently Does Affimed (NASDAQ:AFMD) Use Debt?
Sep 17Affimed Q2 2022 Earnings Preview
Aug 10Affimed: Preparing For Key Inflection Points
Jun 29Does Affimed (NASDAQ:AFMD) Have A Healthy Balance Sheet?
Jun 14Affimed Stock: 3 Points For The Bulls
Apr 09Affimed N.V. (NASDAQ:AFMD) Analysts Just Cut Their EPS Forecasts Substantially
Apr 05Does Affimed (NASDAQ:AFMD) Have A Healthy Balance Sheet?
Dec 14Affimed: Preparing For A Bullish 2022
Oct 12Does Affimed (NASDAQ:AFMD) Have A Healthy Balance Sheet?
Aug 19Affimed: Current Fall And Future Prospects
Jul 07We Discuss Why Affimed N.V.'s (NASDAQ:AFMD) CEO May Deserve A Higher Pay Packet
Jun 08Need To Know: Analysts Just Made A Substantial Cut To Their Affimed N.V. (NASDAQ:AFMD) Estimates
Apr 20CEO
Shawn Leland (40 yo)
less than a year
Tenure
Dr. Shawn M. Leland, Pharm.D. R.Ph. serves as Chief Executive Officer at Afirmed N.V. from September, 2024. He was Interim Chief Executive Officer and Director of Fore Biotherapeutics Inc. since September...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, COO & Member of Management Board | 7.3yrs | €1.26m | 0.89% $ 173.2k | |
Chief Business Officer & Member of Management Board | 3.5yrs | €1.17m | 0.55% $ 107.0k | |
Chief Medical Officer & Member of Management Board | no data | €1.14m | 0.46% $ 90.5k | |
Chief Executive Officer | less than a year | no data | no data | |
Founder & Consultant | 24.9yrs | no data | no data | |
Head of Finance & Administration | 9.9yrs | no data | no data | |
Head of Investor Relations & Director of Investor Relations | no data | no data | no data | |
Vice President of Marketing & Communications | no data | no data | no data |
7.3yrs
Average Tenure
57yo
Average Age
Experienced Management: AFMD's management team is seasoned and experienced (7.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Chairman of Supervisory Board | 17.9yrs | €162.00k | 0.24% $ 45.9k | |
Member of Scientific Advisory Board | 9.5yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 9.5yrs | no data | no data | |
Member of Scientific Advisory Board | 8.9yrs | no data | no data |
9.5yrs
Average Tenure
Experienced Board: AFMD's board of directors are considered experienced (9.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 15:37 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Affimed N.V. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Birchenough | BMO Capital Markets Equity Research |
Li Wang Watsek | Cantor Fitzgerald & Co. |
Bradley Canino | Credit Suisse |